Quest 10 Wealth Builders’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Quest 10 Wealth Builders’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.97K	Hold	16	–	–	﹤0.01%	561
2026 Q1	$3.21K	Hold	16	–	–	﹤0.01%	576
2025 Q4	$3.3K	Hold	16	–	–	﹤0.01%	537
2025 Q3	$2.87K	Hold	16	–	–	﹤0.01%	570
2025 Q2	$2.58K	Hold	16	–	–	﹤0.01%	565
2025 Q1	$2.72K	Hold	16	–	–	﹤0.01%	536
2024 Q4	$2.66K	Buy	+16	New	+$2.73K	﹤0.01%	578

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Quest 10 Wealth Builders's FBT Position: Q2 2026 in Review

Quest 10 Wealth Builders held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2026 at 16 shares worth $3.97K. The position accounts for ﹤0.01% of the portfolio, ranked #561.

Quest 10 Wealth Builders first reported a position in FBT in Q4 2024 and has held it in 7 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Quest 10 Wealth Builders held 16 shares of First Trust NYSE Arca Biotechnology Index Fund worth $3.97K as of Q2 2026.
Quest 10 Wealth Builders left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Quest 10 Wealth Builders's portfolio in Q2 2026, its #561 holding.
Quest 10 Wealth Builders first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2024 and has held it in 7 quarters since.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Quest 10 Wealth Builders's 13F filing for Q2 2026, filed 24 Jul 2026.